In our Health & Beauty Division, we have highly regarded and long established product brands such as No7, Boots Soltan and Botanics, together with newer brands such as Boots Pharmaceuticals and Boots Laboratories. Product innovation and development, packaging and product marketing capabilities are key skills which enable us to develop new and existing brands.
We are continuing to internationalise our key product brands, increasingly selling them through select retail partners, our own and third party internet shopping sites, and independent pharmacies. In the US, where Boots product brands have been sold through Target for many years, we are, in addition, introducing No7 and other key Boots product brands into the drugstore channel through Walgreens on a phased basis. In Europe, our Boots Laboratories range is sold by independent pharmacies in five countries.
In addition, we have long term partnerships with a select number of third party brand owners to sell their products in Boots stores on an exclusive basis, sharing in the future brand equity. Most recently, we have established a specialist investment fund to invest in small and medium sized consumer brand businesses within the health, wellness, beauty and personal care sector. We continue to manufacture a significant proportion of our most popular own brand and exclusive products.
In our Pharmaceutical Wholesale Division and associates, Almus, our range of generic medicines, is sold in five countries and Alvita, our range of patient care products, is sold in six countries.
*All figures are approximations as at 31 March 2014 and include associates and joint ventures.